Progressive Myoclonic Epilepsy’-like presentation of Cerebrotendinous Xanthomatosis in an Indian Family with A Novel C.646+1G>A Splice Site Mutation
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 15, 100401
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Movement disorders in cerebrotendinous xanthomatosisParkinsonism & Related Disorders, 2019
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and TerminologyEpilepsia, 2017
- The Effects of ABCC2 G1249A Polymorphism on the Risk of Resistance to Antiepileptic Drugs: A Meta-Analysis of the LiteratureGenetic Testing and Molecular Biomarkers, 2014
- Myoclonus and dystonia in cerebrotendinous xanthomatosisMovement Disorders, 2012
- A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 geneClinical Neurology and Neurosurgery, 2012
- Cerebrotendinous Xanthomatosis Revealed in Drug-Resistant Epilepsy Diagnostic WorkupThe American Journal of the Medical Sciences, 2012
- Blood–brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activityBrain Research, 2010
- Progressive myoclonic epilepsies: a review of genetic and therapeutic aspectsThe Lancet Neurology, 2005
- Epileptic Seizure as a Presenting Symptom of Cerebrotendinous XanthomatosisEpilepsia, 1991
- EEG in Cerebrotendinous Xanthomatosis (CTX)Clinical Electroencephalography, 1982